Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Even Fossum

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Scientific Reports|February 14, 2019
Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery siteAnna Lysén, Ranveig Braathen, Arnar Gudjonsson, et al.
Virology Journal|March 6, 2024
Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023Even Fossum, Andreas Rohringer, Torstein Aune, et al.
Scandinavian Journal of Immunology|December 19, 2021
Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infectionAnna Lysén, Arnar Gudjonsson, Demo Yemane Tesfaye, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2020
A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and InfluenzaRanveig Braathen, Heidi Cecilie Larsen Spång, Daniëla Maria Hinke, et al.
Journal of Virology|September 24, 2010
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signalingKatharina Heinzelmann, Barbara A Scholz, Agnes Nowak, et al.
Frontiers in Immunology|March 17, 2022
Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza InfectionDemo Yemane Tesfaye, Sonja Bobic, Anna Lysén, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune ResponseEven Fossum, Demo Yemane Tesfaye, Sonja Bobic, et al.
Immunohorizons|April 26, 2019
The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface MoleculesRanveig Braathen, Heidi C L Spång, Mona M Lindeberg, et al.
European Journal of Immunology|November 21, 2014
Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virusEven Fossum, Gunnveig Grødeland, Dorothea Terhorst, et al.
Scientific Reports|October 29, 2024
Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patientIgnacio Garcia, Jon Bråte, Even Fossum, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Scientific Reports|February 14, 2019
Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery siteAnna Lysén, Ranveig Braathen, Arnar Gudjonsson, et al.
Virology Journal|March 6, 2024
Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023Even Fossum, Andreas Rohringer, Torstein Aune, et al.
Scandinavian Journal of Immunology|December 19, 2021
Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I:C) enhances T cell responses and protects against influenza infectionAnna Lysén, Arnar Gudjonsson, Demo Yemane Tesfaye, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2020
A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and InfluenzaRanveig Braathen, Heidi Cecilie Larsen Spång, Daniëla Maria Hinke, et al.
Journal of Virology|September 24, 2010
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signalingKatharina Heinzelmann, Barbara A Scholz, Agnes Nowak, et al.
Frontiers in Immunology|March 17, 2022
Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza InfectionDemo Yemane Tesfaye, Sonja Bobic, Anna Lysén, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 28, 2020
Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune ResponseEven Fossum, Demo Yemane Tesfaye, Sonja Bobic, et al.
Immunohorizons|April 26, 2019
The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface MoleculesRanveig Braathen, Heidi C L Spång, Mona M Lindeberg, et al.
European Journal of Immunology|November 21, 2014
Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virusEven Fossum, Gunnveig Grødeland, Dorothea Terhorst, et al.
Scientific Reports|October 29, 2024
Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patientIgnacio Garcia, Jon Bråte, Even Fossum, et al.
Pageof 5